Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 733

1.

Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.

Sulkowski MS, Mehta SH, Torbenson MS, Higgins Y, Brinkley SC, de Oca RM, Moore RD, Afdhal NH, Thomas DL.

AIDS. 2007 Oct 18;21(16):2209-16.

PMID:
18090048
[PubMed - indexed for MEDLINE]
2.

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, Mehta S, Kirk GD, Nelson K, Afdhal N, Thomas DL.

Hepatology. 2006 Apr;43(4):788-95.

PMID:
16557548
[PubMed - indexed for MEDLINE]
3.

Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.

Bonnard P, Lescure FX, Amiel C, Guiard-Schmid JB, Callard P, Gharakhanian S, Pialoux G.

J Viral Hepat. 2007 Nov;14(11):806-11.

PMID:
17927617
[PubMed - indexed for MEDLINE]
4.

HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease.

Nunes D, Fleming C, Offner G, O'Brien M, Tumilty S, Fix O, Heeren T, Koziel M, Graham C, Craven DE, Stuver S, Horsburgh CR Jr.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):538-44.

PMID:
16284529
[PubMed - indexed for MEDLINE]
5.

Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.

Bani-Sadr F, Lapidus N, Bedossa P, De Boever CM, Perronne C, Halfon P, Pol S, Carrat F, Cacoub P; French National Agency for Research on AIDS; Viral Hepatitis-HC02-Ribavic Study Team.

Clin Infect Dis. 2008 Mar 1;46(5):768-74. doi: 10.1086/527565.

PMID:
18248298
[PubMed - indexed for MEDLINE]
Free Article
6.

Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.

Martin-Carbonero L, de Ledinghen V, Moreno A, Maida I, Foucher J, Barreiro P, Romero M, Satta G, Garcia-Samaniego J, Gonzalez-Lahoz J, Soriano V.

J Viral Hepat. 2009 Nov;16(11):790-5. doi: 10.1111/j.1365-2893.2009.01133.x. Epub 2009 Apr 28.

PMID:
19413693
[PubMed - indexed for MEDLINE]
7.

Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients.

Tural C, Fuster D, Tor J, Ojanguren I, Sirera G, Ballesteros A, Lasanta JA, Planas R, Rey-Joly C, Clotet B.

J Viral Hepat. 2003 Mar;10(2):118-25.

PMID:
12614468
[PubMed - indexed for MEDLINE]
8.

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.

Kelleher TB, Mehta SH, Bhaskar R, Sulkowski M, Astemborski J, Thomas DL, Moore RE, Afdhal NH.

J Hepatol. 2005 Jul;43(1):78-84. Epub 2005 Apr 25.

PMID:
15894397
[PubMed - indexed for MEDLINE]
9.

HCV virological response during treatment of chronic hepatitis C is associated with liver histological improvement in patients with HCV/HIV co-infection.

Castro G, Ramalho LN, Zucoloto S, Martinelli Ade L, Figueiredo JF.

Braz J Infect Dis. 2008 Jun;12(3):180-5.

PMID:
18833400
[PubMed - indexed for MEDLINE]
Free Article
10.

Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine.

Macías J, Castellano V, Merchante N, Palacios RB, Mira JA, Sáez C, García-García JA, Lozano F, Gómez-Mateos JM, Pineda JA.

AIDS. 2004 Mar 26;18(5):767-74.

PMID:
15075511
[PubMed - indexed for MEDLINE]
11.

Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02.

Halfon P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Cacoub P.

Antivir Ther. 2009;14(2):211-9.

PMID:
19430096
[PubMed - indexed for MEDLINE]
12.

[Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].

Stránský J, Ryzlová M, Striteský J, Horák J.

Vnitr Lek. 2002 Oct;48(10):924-8. Czech.

PMID:
16737138
[PubMed - indexed for MEDLINE]
13.

Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.

Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Ferraz ML, Silva AE.

Liver Int. 2008 Apr;28(4):486-93. doi: 10.1111/j.1478-3231.2008.01675.x.

PMID:
18339075
[PubMed - indexed for MEDLINE]
14.

Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002.

Schiavini M, Angeli E, Mainini A, Zerbi P, Duca PG, Gubertini G, Vago L, Fociani P, Giorgi R, Cargnel A.

HIV Med. 2006 Jul;7(5):331-7.

PMID:
16945079
[PubMed - indexed for MEDLINE]
15.

10-Year follow-up after interferon-alpha therapy for chronic hepatitis C.

Lau DT, Kleiner DE, Ghany MG, Park Y, Schmid P, Hoofnagle JH.

Hepatology. 1998 Oct;28(4):1121-7.

PMID:
9755252
[PubMed - indexed for MEDLINE]
16.

Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.

Barreiro P, Martín-Carbonero L, Núñez M, Rivas P, Morente A, Simarro N, Labarga P, González-Lahoz J, Soriano V.

Clin Infect Dis. 2006 Apr 1;42(7):1032-9. Epub 2006 Feb 21.

PMID:
16511772
[PubMed - indexed for MEDLINE]
Free Article
17.

Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.

Kovari H, Ledergerber B, Battegay M, Rauch A, Hirschel B, Foguena AK, Vernazza P, Bernasconi E, Mueller NJ, Weber R.

Clin Infect Dis. 2010 Feb 15;50(4):502-11. doi: 10.1086/649922.

PMID:
20085465
[PubMed - indexed for MEDLINE]
Free Article
18.

Natural course of asymptomatic hepatitis C virus-infected patients and hepatocellular carcinoma after interferon therapy.

Okanoue T, Minami M, Makiyama A, Sumida Y, Yasui K, Itoh Y.

Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S89-91.

PMID:
16234069
[PubMed - indexed for MEDLINE]
19.
20.

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus.

Macías J, Berenguer J, Japón MA, Girón JA, Rivero A, López-Cortés LF, Moreno A, González-Serrano M, Iribarren JA, Ortega E, Miralles P, Mira JA, Pineda JA.

Hepatology. 2009 Oct;50(4):1056-63. doi: 10.1002/hep.23136.

PMID:
19670415
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk